Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp, Bloomberg ...

Bloomberg reports today that Abbott (NYSE: ABT) is close to a deal to acquire diagnostics developer Exact Sciences (Nasdaq:EXAS).

Scientists have created swallowable microsphere “pills” packed with engineered bacteria that can detect signs of gut disease, ...

MORE than half of men have ignored potentially worrying physical or mental health issues, according to a report. But of those ...

In their common MOU, Mainz Biomed and OncoVanguard8 have outlined core commercial, legal and regulatory terms as well as the ...

In this fictional tale, a skeptical physician’s scrutiny reshapes a sales rep’s journey and forces truth to prevail over glossy marketing claims.

Swapping colonoscopies for swallowing a pill packed with bacteria that can read the condition of our gut could revolutionize ...

Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...

Dr Moni Abraham Kuriakose –co-founder, medical director, and CEO of Karkinos Kerala – is a leading surgical oncologist and ...

Artificial intelligence (AI) is set to transform the care of women with cancer. From early detection via digital phenotyping ...

Serum DR-70 levels are higher in bladder cancer patients, especially in muscle-invasive cases, indicating potential for diagnosis and staging. Current diagnostic methods for bladder cancer are ...

Your primary care provider is more than just your annual stop for routine checkups. They're also the central hub for coordinating your health care, from specialist visits to follow-up testing ...